Red Lake Nation News - Babaamaajimowinan (Telling of news in different places)

FDA to require enhanced warnings on labels of certain drug-coated medical devices


August 8, 2019

This 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. (AP Photo/Andrew Harnik, File) ORG XMIT: MIN1906211122490662

The U.S. Food and Drug Administration will allow medical devices for the legs coated with the drug paclitaxel to remain on the market, but with increased scrutiny and enhanced patient warnings after the discovery that the devices are associated with long-term higher risks of death.

An updated letter to doctors posted by the FDA on Wednesday says the agency is "working with" devicemakers to include warnings on product labels explaining what's known about the risk. While the agency will continue allowing commercial sales of the devices, patients treated in clinical trials will receive enhanced informed consent disclosures and will be subject to closer ongoing scrutiny by safety-monitoring boards.


Reader Comments


Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2020

Rendered 09/12/2020 14:01